|
|
|||||
|
|
ThermoEnergy Announces New Advisory Director Tuesday October 2, 2007 8:30 am ET LITTLE ROCK, Ark., Oct. 2 /PRNewswire-FirstCall/ -- ThermoEnergy Corporation ("ThermoEnergy") (OTC Bulletin Board: TMEN - News) is pleased to announce the appointment of Mr. Donald F. Farley to the Company's Advisory Board of Directors. Mr. Farley is Chief Executive Officer of Spencer Trask's Specialty Group, LLC. The Group is focused on emerging and development companies specializing in pharmaceuticals, medical devices, diagnostics, specialty chemicals and food ingredients. Mr. Farley began his professional career with Pfizer, Inc. in 1965, and has extensive general management, international business and technical experience. During his 33 year career with Pfizer, Mr. Farley served as President of Pfizer Consumer Health Care, and as President of Pfizer Food Science Group. Mr. Farley received his BS in chemical engineering from The University of Rhode Island and his MBA from The University of Hartford. Mr. Farley is Chairman of Vyteris, Inc., a drug delivery company with unique technology. He also serves as Chairman of Stolle Milk Biologics, Inc. a provider of healthful ingredients from milk. Mr. Farley currently serves on several Boards including Minrad, a surgical device and pain management company; Verification Technologies, Inc., developers of product authentication technology; Wynden Pharmaceuticals; and Healthcare Providers Direct. Development activities with other Specialty Group, LLC clients include technologies related to conductive inks, proprietary nutraceuticals and food products, and bio-based, environmentally friendly specialty chemicals. Mr. Farley also privately invests in businesses and is principal investor and adviser to Ready Minds, Inc. a career counseling startup company. Mr. Farley is a member of the University of Rhode Island President's Advisory Council. "The Company is pleased to have such a distinguished and accomplished individual join the ThermoEnergy team in the role of Advisory Director," said Dennis C. Cossey, ThermoEnergy's Chairman and CEO. "The pharmaceutical industry is a primary target market for our Castion water division, and Don's extensive experience and background within the industry will be invaluable as the Company seeks to establish a presence in this key market. In addition, his current position as senior management with one of the oldest New York City investment banking houses will be of significant importance as the Company seeks to raise future growth capital," added Cossey. About ThermoEnergy Founded in 1988, ThermoEnergy is an integrated technologies company engaged in the worldwide commercialization of patented and/or proprietary municipal and industrial wastewater treatment and power generation technologies. The economic and environmental matrix of the Company's technologies represents a significant advancement in these key infrastructure industries. The Company currently has offices in Little Rock, AR, Hudson, MA, Worcester, MA and New York, NY. Additional information on the Company and its technologies can be found on its website at www.thermoenergy.com and www.castion.com. |
|||||
| |
| |
|